Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

AIMS/HYPOTHESIS: Metformin is the most-prescribed oral medication to lower blood glucose worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in reducing risk of cardiovascular disease, the most costly complication of type 2 diabetes. We aimed to systematically ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Simon J., Leaver, James K., Irving, Greg J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552849/
https://www.ncbi.nlm.nih.gov/pubmed/28770324
http://dx.doi.org/10.1007/s00125-017-4337-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552849/
https://www.ncbi.nlm.nih.gov/pubmed/28770324
http://dx.doi.org/10.1007/s00125-017-4337-9

Ejemplares similares